Modulation of surface transferrin receptors in lymphoid cells de novo infected with human immunodeficiency virus type-1

Cell Biochemistry and Function

Volumn 17, Issue 1, 1999, Pages 47-55

  Savarino, A ^b   Calosso, L ^c   Piragino, A ^c   Martini, C ^a   Gennero, L ^c   Pescarmona, G P ^c   Pugliese, A ^c  

^a AMEDEO DI SAVOIA HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c NONE

Author keywords

CD71; Cytopathic effect; HIV 1; Sodium citrate; Transferrin receptor

Indexed keywords

CELL SURFACE RECEPTOR; CITRATE SODIUM; IRON CHELATING AGENT; TRANSFERRIN RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; LYMPHOID CELL LINE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

ADP-RIBOSYL CYCLASE; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; CHELATING AGENTS; CITRATES; DOWN-REGULATION; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; IRON; MEMBRANE GLYCOPROTEINS; NAD+ NUCLEOSIDASE; RECEPTORS, TRANSFERRIN;

EID: 0032967687     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0844(199903)17:1<47::AID-CBF810>3.0.CO;2-V     Document Type: Article

References (30)

1. Baker, E. and Morgan, H. (1994). Iron transport. In: Iron Metabolism in Health and Disease. (Brock, J. H., et al., eds.) W. B. Saunders Company Ltd: London, U.K., pp. 63-95.
2. Cano, E., Pizzarro, A., Redondo, J. M., Sanchez-Madrid, F., Bernabeu, C. and Fresno, M. (1990). Induction of T cell activation by monoclonal antibodies specific for the transferrin receptor. Eur. J. Immunol., 20, 765 770.
3. Harford, J. B., Rouault, T. A. and Klausner, R. D. (1994). The control of cellular iron homeostasis. In: Iron Metabolism in Health and Disease. (Brock, J. H., et al., eds.) W. B. Saunders Company Ltd: London, U.K., pp. 123 150.
4. Trowbridge, I. A. (1995). Overview of CD71. In: Leukocyte Typing V: White Cells Differentiation Antigens, Vol. I. (Schlossman, S. F., et al., eds.) Oxford University Press: New York, New York, pp. 1139 1141.
5. Testa, U., Conti, L., Sposi, N. M., Varano, B., Tritarelli, E., Malorni, W., Samoggia, P., Rainaldi, G., Peschle, C., Belardelli, F. and Gessani, S. (1995). IFN-β selectively down-regulates transferrin receptor expression in human peripheral blood macrophages by a post-translational mechanism. J. Immunol., 155, 427 435.
6. Calosso, L., Savarino, A., Pugliese, A., Musso, T. and Malavasi, F. (1997). Modulation patterns of CD71 (transferrin receptor) induced by IFN-γ in HIV-infected lymphocytic and monocytic cell lines. In: International Conference on HIV and Iron. Brugge, Belgium, 14 15 March. Abstract No. P.A. 1.
7. Fuchs, D., Zangerle, R., Artner-Dworzak, E., Weiss, G., Fritsch, P., Tils, G. P., Dierich, M. P. and Wachter, H. (1993) Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infection. Eur. J. Haematol., 50, 90 94.
8. Boelaert, J. R., Weinberg, G. A. and Weinberg, E. D. (1996). Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management. Infect. Ag. Dis., 5, 36-46.
9. Pugliese, A., Savarino, A., Cantamessa, C. and Torre, D. (1996). Influence of fibronectin on HIV-1 infection and capability of binding to platelets. Cell Biochem. Funct., 14, 291-296.
10. Funaro, A., Reinis̊, M., Trubiani, O., Santi, S., Di Primio R. and Malavasi, F. (1998). CD38 functions are regulated through an internalization step. J. Immunol., 160, 2238-2247.
11. Noraz, N., Verrier, B., Fraisier, C. and Desgranges, C. (1995). Cell surface phenotypic changes induced in H9 T cells chronically infected with HTLV type I or HIV type I or coinfected with the two viruses. AIDS Res. Hum. Retroviruses, 11, 145-154.
12. Savarino, A., Martini, C., Cantamessa, C., Orofino, G. C., Castelli, L., Pich, P. G., Sinicco, A. and Pugliese, A. (1997). Apoptotic DNA fragmentation and its in vitro prevention by nicotinamide in lymphocytes from HIV-1-seropositive patients and in HIV-1-infected cells. Cell Biochem. Fuct., 15, 171 179.
13. Savarino, A., Pugliese, A., Martini, C., Pich, P. G., Pescarmona, G. P. and Malavasi, F. (1996). Investigation of the potential role of membrane CD38 in protection against cell death induced by HIV-1. J. Biol. Reg. Homeost. Ag., 10, 13 18.
14. + T cells from normal and immunodeficient donors using directly conjugated anti-cytokine antibodies and three-colour flow cytometry. Clin. Exp. Immunol., 105, 517-522.
15. Ross, C., Hansen, M. B., Schyberg, T. and Berg, K. (1990). Autoantibodies to crude human leukocyte interferon (IFN), native human IFN, recombinant human IFN-alpha 2b and human IFN-gamma in healthy blood donors. Clin. Exp. Immunol., 82, 57-62.
16. Hesselgasser, J., Liang, M., Hoxie, J., Greenberg, M., Brassl, F., Orsini, M. J., Taub, D. and Horuk, R. (1998). Identification and characterization of the CXCR-4 chemokine receptor in human T cell lines: ligand binding, biological activity, and HIV-1 infectivity. J. Immunol., 160, 877 883.
17. Hershko, C. (1994). Iron chelators. In: Iron Metabolism in Health and Disease. (Brock, J. H., et al., eds.) W. B. Saunders Company Ltd: London, U.K., pp. 391-426.
18. Stevenson, M., Zhang, X. H. and Volsky, D. J. (1987). Downregulation of cell surface molecules during noncytopathic infection of T cells with human immunodeficiency virus. J. Virol., 61, 3741-3748.
19. Zolotukhin, A. S., Harford, J. B. and Felber, B. K. (1994). Rev of human immunodeficiency virus and Rex of the human T-cell leukemia virus type I can counteract an mRNA downregulatory element of the transferrin receptor mRNA. Nucleic Acid Res., 22, 4725 4732.
20. Wrightham, M., Schimpf, A., Pennington, T. H., Walker, F. and Sewell, H. F. (1991). HIV induces modulation of functionally important cellular antigens. Clin. Exp. Immunol., 85, 75-79.
21. Piedimonte, G., Petronini, P. G., Guetard, V., Favier, V., Borghetti, A. F. and Montagnier, L. (1990). Protease activation during HIV infection in a CD4-positive cell line. AIDS Res. Hum. Retroviruses, 6, 251-260.
22. Cinatl, J., Scholz, M., Weber, B., Cinatl, J., Rabenau, H., Markus, B. H., Enke, A. and Doerr, H. W. (1997). Effects of desferrioxamine on human cytomegalovirus replication and expression of HLA antigens and adhesion molecules in human vascular endothelial cells. Transplant. Immunol., 3, 313-320.
23. Tabor, E., Epstein, J. S., Hewlett, I. K. and Lee, S. F. (1991). Inhibition by desferrioxamine of in-vitro replication of HIV-1. Lancet, 337, 795.
24. Baruchel, S., Gao, Q. and Weinberg, S. A. (1991). Desferrioxamine and HIV. Lancet, 337, 1356.
25. Lazdins, J. K., Alteri, E., Klimkait, T., Woods-Kook, K., Walker, M. R., Gou He, G. and Pencioni, B. (1991). Lack of effect of desferrioxamine on in vitro HIV-1 replication. Lancet, 338, 1341 1342.
26. Santos, M. and de Sousa, M. (1994). In vitro modulation of T-cell surface molecules by iron. Cell. Immunol., 154, 498-506.
27. Boelaert, J. R., Gordeuk, V. R., Piette, J. and Weinberg, G. A. (1997). Conference report: International Conference on HIV and Iron, Brugge 1997. Trop. Med. Internat. Health, 2, 1102 1106.
28. Gennero, L., Savarino, A., Martini, C., Barilaro, M. R., Marra, E., Azzolino, O., Orofino, G. C., Pes, M., Piscina, A., Pich, P. G., Pugliese, A. and Pescarmona, G. P. (1997). Correlation between markers of iron metabolism in HIV-seropositive individuals and in HIV-infected cells. Ligand Assay, 2, 182-190.
29. Weinberg, E. D. (1996). Iron withholding: a defense against viral infections. Biometals, 9, 393-399.
30. Shatrov, V. A., Boelaert, J. R., Dröge, W. and Lehman, V. (1997). Iron chelation decreases HIV-1 tat potentiated TNF-induced NF-κB activation in Jurkat cells. Eur. Cytokine Network, 8, 37 43.